Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nico Gabriel

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
AIDS (London, England)|October 7, 2022
Estimated changes in price discounts for tenofovir-inclusive HIV treatments following introduction of tenofovir alafenamideSean Dickson, Nico Gabriel, Inmaculada Hernandez
JAMA Health Forum|November 17, 2023
Trends in Proportion of Medicare Part D Claims Subject to 340B Discounts, 2013-2020Sean Dickson, Nico Gabriel, Inmaculada Hernandez
Health Affairs (Project Hope)|August 7, 2023
Changes In Net Prices And Spending For Pharmaceuticals After The Introduction Of New Therapeutic Competition, 2011-19Sean Dickson, Nico Gabriel, Inmaculada Hernandez
Journal of Managed Care & Specialty Pharmacy|October 27, 2023
Nonfederal average manufacturer price to estimate savings generated by minimum discounts under the Inflation Reduction ActInmaculada Hernandez, Nico Gabriel, Sean Dickson
Journal of Managed Care & Specialty Pharmacy|July 31, 2023
Estimated discounts generated by Medicare drug negotiation in 2026Inmaculada Hernandez, Nico Gabriel, Sean Dickson
JAMA Network Open|July 13, 2023
Contextualizing the Price of Biosimilar Adalimumab Based on Historical Rebates for the Original Formulation of Branded AdalimumabSean R Dickson, Nico Gabriel, Inmaculada Hernandez
Journal of Health Politics, Policy and Law|July 22, 2022
Reduction in Medicaid Rebates Paid by Pharmaceutical Manufacturers for Outpatient Infused, Injected, Implanted, Inhaled, or Instilled Drugs: The 5i LoopholeSean Dickson, Nico Gabriel, Walid Gellad, et al.
JAMA Health Forum|June 16, 2023
Estimated Changes in Insulin Prices and Discounts After Entry of New Insulin Products, 2012-2019Sean Dickson, Nico Gabriel, Walid F Gellad, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 12, 2021
Joint Latent Class Analysis of Oral Anticoagulation Use and Risk of Stroke or Systemic Thromboembolism in Patients with Atrial FibrillationNemin Chen, Nico Gabriel, Maria M Brooks, et al.
JAMA Network Open|June 14, 2023
Assessment of Commercial and Mandatory Discounts in the Gross-to-Net Bubble for the Top Insulin Products From 2012 to 2019Sean R Dickson, Nico Gabriel, Walid F Gellad, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
AIDS (London, England)|October 7, 2022
Estimated changes in price discounts for tenofovir-inclusive HIV treatments following introduction of tenofovir alafenamideSean Dickson, Nico Gabriel, Inmaculada Hernandez
JAMA Health Forum|November 17, 2023
Trends in Proportion of Medicare Part D Claims Subject to 340B Discounts, 2013-2020Sean Dickson, Nico Gabriel, Inmaculada Hernandez
Health Affairs (Project Hope)|August 7, 2023
Changes In Net Prices And Spending For Pharmaceuticals After The Introduction Of New Therapeutic Competition, 2011-19Sean Dickson, Nico Gabriel, Inmaculada Hernandez
Journal of Managed Care & Specialty Pharmacy|October 27, 2023
Nonfederal average manufacturer price to estimate savings generated by minimum discounts under the Inflation Reduction ActInmaculada Hernandez, Nico Gabriel, Sean Dickson
Journal of Managed Care & Specialty Pharmacy|July 31, 2023
Estimated discounts generated by Medicare drug negotiation in 2026Inmaculada Hernandez, Nico Gabriel, Sean Dickson
JAMA Network Open|July 13, 2023
Contextualizing the Price of Biosimilar Adalimumab Based on Historical Rebates for the Original Formulation of Branded AdalimumabSean R Dickson, Nico Gabriel, Inmaculada Hernandez
Journal of Health Politics, Policy and Law|July 22, 2022
Reduction in Medicaid Rebates Paid by Pharmaceutical Manufacturers for Outpatient Infused, Injected, Implanted, Inhaled, or Instilled Drugs: The 5i LoopholeSean Dickson, Nico Gabriel, Walid Gellad, et al.
JAMA Health Forum|June 16, 2023
Estimated Changes in Insulin Prices and Discounts After Entry of New Insulin Products, 2012-2019Sean Dickson, Nico Gabriel, Walid F Gellad, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 12, 2021
Joint Latent Class Analysis of Oral Anticoagulation Use and Risk of Stroke or Systemic Thromboembolism in Patients with Atrial FibrillationNemin Chen, Nico Gabriel, Maria M Brooks, et al.
JAMA Network Open|June 14, 2023
Assessment of Commercial and Mandatory Discounts in the Gross-to-Net Bubble for the Top Insulin Products From 2012 to 2019Sean R Dickson, Nico Gabriel, Walid F Gellad, et al.
Pageof 5